Long-Term Outcomes of EUS-Guided Pancreatic Duct Drainage for the Management of Benign Pancreaticojejunostomy Anastomotic Stricture—A Retrospective Cohort Study
Journal of Clinical Medicine · 28.11.2025 · 14 (23) · 8439
DOI: 10.3390/jcm14238439 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.11.2025. Verfasst von Indria Melianti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Endoscopic ultrasound-guided pancreatic duct drainage (EUS-guided PDD) has emerged as an important technique for managing pancreaticojejunostomy anastomotic strictures (PJAS) following pancreatoduodenectomy. However, long-term outcome data remain limited. This study aimed to evaluate the long-term outcomes of EUS-guided PDD for benign PJAS.
Methods
This single-center retrospective cohort study included 46 patients who underwent technically successful EUS-guided PDD for benign PJAS between May 2011 and June 2025. The primary outcome was cumulative clinical fistula patency assessed by Kaplan–Meier analysis. Secondary outcomes included adverse events and risk factors for re-intervention.
Results
Technical success was 95.83% (46/48), with clinical success in all technically successful cases. Cumulative clinical fistula patency rates were 82.20% at 1 year and 75.90% at 3 and 5 years. Postprocedural adverse events occurred in 28.26%. Unplanned re-intervention was required in 19.57%, exclusively among patients symptomatic before the initial procedure; symptomatic-status effects were therefore non-estimable. No independent predictors of unplanned re-intervention were detected, and no differences were observed between EUS-guided pancreaticogastrostomy (EUS-guided PGS) and EUS-guided pancreatojejunostomy (EUS-guided PJS).
Conclusions
EUS-guided PDD achieved high technical and clinical success with durable long-term patency (82.20% at 1 year; 75.90% at 3 and 5 years). Differences between EUS-guided PGS and EUS-guided PJS and independent predictors of unplanned re-intervention were not detected; because all nine re-interventions occurred in patients symptomatic at baseline and none in asymptomatic patients, symptomatic-status effects were non-estimable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
ORCID-Profile: Indria Melianti, Kazuo Hara, Takamichi Kuwahara, Shin Haba, Nozomi Okuno, Shimpei Matsumoto, Hiroki Koda, Keigo Oshiro, Tomoki Ogata
Zitieren
APA
Melianti, I., Hara, K., Kuwahara, T., Haba, S., Okuno, N., Matsumoto, S., Koda, H., Oshiro, K., & Ogata, T. (2025). Long-Term Outcomes of EUS-Guided Pancreatic Duct Drainage for the Management of Benign Pancreaticojejunostomy Anastomotic Stricture—A Retrospective Cohort Study. Journal of Clinical Medicine, 14(23), 8439. https://doi.org/10.3390/jcm14238439
Vancouver
Melianti I, Hara K, Kuwahara T, Haba S, Okuno N, Matsumoto S, et al. Long-Term Outcomes of EUS-Guided Pancreatic Duct Drainage for the Management of Benign Pancreaticojejunostomy Anastomotic Stricture—A Retrospective Cohort Study. Journal of Clinical Medicine. 2025;14(23):8439. doi:10.3390/jcm14238439
BibTeX
@article{Melianti2025,
author = {Melianti, Indria and Hara, Kazuo and Kuwahara, Takamichi and Haba, Shin and Okuno, Nozomi and Matsumoto, Shimpei and Koda, Hiroki and Oshiro, Keigo and Ogata, Tomoki},
title = {Long-Term Outcomes of EUS-Guided Pancreatic Duct Drainage for the Management of Benign Pancreaticojejunostomy Anastomotic Stricture—A Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {23},
pages = {8439},
doi = {10.3390/jcm14238439}
}
EUVIMED